Medical Device | December 08, 2021
Venair showcases its Vena Flexip and Flexpure
The company plans to expand their capacity to meet the needs of pharma and biotech industries
The company plans to expand their capacity to meet the needs of pharma and biotech industries
This is the fourth facility from the company to receive this registration
Sputnik M is a new member of the Sputnik vaccines family
The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.
The hospital is scheduled to open in 2024 with a bed capacity of 225
Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever
She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
Officials from ACG signed the MoU with the Maharashtra government for the Rs 600 crore investment in the backward region of Marathwada
Subscribe To Our Newsletter & Stay Updated
